Soleno Therapeutics (NASDAQ:SLNO) Stock Price Expected to Rise, HC Wainwright Analyst Says
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) had its price objective raised by stock analysts at HC Wainwright from $70.00 to $100.00 in a report released on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target would suggest a potential upside of 46.50% from the company’s previous close. […]
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) had its price objective raised by stock analysts at HC Wainwright from $70.00 to $100.00 in a report released on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target would suggest a potential upside of 46.50% from the company’s previous close. […]
